文献速递泌尿与男性生殖病理

前列腺病理报告当前实践:泌尿专科与普通病理医生的调查结果

Current practices in prostate pathology reporting: results from a survey of genitourinary and general pathologists.
PubMed 文献 · Histopathology · 2025-05-13

通过REDCap对全球175名病理医生进行问卷调查,回应率83%,评估前列腺病理报告实践模式的异同。多数议题达成共识,但不同学会和执业环境间存在显著差异,尤其在导管内癌报告、Grade Group分级和根治标本%4报告等方面。

要点

  • 96%报告Gleason评分和Grade Group,94%报告%4。
  • 孤立iIDC时89%用基底细胞标志物,但≥GG2癌旁IDC仅37%使用。
  • 根治标本90%报告%4,但整体分级≥7时仅53%报告。

核心结论

  • 大多数前列腺病理报告议题已达成共识,但不同学会和执业环境间仍存在显著差异。

研究设计与样本

  • 多机构问卷调查,通过REDCap发放,全球175名病理医生参与,受邀病理医生回应率83%。

主要发现

  • 96%报告Gleason评分和Grade Group,94%报告%4。
  • 63%报告 intervening benign tissue,37%减去。
  • 系统穿刺中聚集分级和体积估计分别由73%和54%报告,靶向穿刺分别为83%和62%。
  • 81%报告筛状结构。
  • 孤立iIDC时89%使用基底细胞标志物,伴GG1癌时82%,伴≥GG2时37%。

关键数值与推荐

  • 根治标本中90%报告%4,但整体分级≥7时仅53%报告。
  • Gleason 3+3=6且%4<5%的肿瘤,64%分级为GG2。
  • 74%使用<5% cutoff定义三级模式,80%将>5%的4或5级模式报告为次要模式。
  • 59%基于主导结节进行分级。

临床怎么用

  • 应关注IDC报告时基底细胞标志物使用的差异,尤其在≥GG2癌旁。
  • 根治标本中%4报告率在整体分级≥7时下降,需规范。
  • 聚集分级和体积估计在系统与靶向穿刺中报告率不同,需统一标准。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

AIMS: Standardizing pathology reporting protocols through peer consensus review is critical for the best quality of care metrics. Reporting heterogeneity due to discrepancies among professional societies and practice patterns may lead to heterogeneous management and treatment approaches. This issue prompted a multi-institutional survey of pathologists to address potential similarities or differences in trends and practice patterns in prostate pathology reporting worldwide. METHODS AND RESULTS: A REDCap survey was distributed among 175 pathologists worldwide, recruited through invitations and social media. The response rate among invited pathologists was 83%. The practice locations were as follows: North America (USA, Canada, and Mexico, 62%), Europe (17%), Australia/New Zealand (3%), Central/South America (2%), Asia (13%), and Africa (2%). Most pathologists practiced for <5 years (28%). A genitourinary (GU) pathology fellowship was completed by 37%, 58% practiced in a subspecialized setting, and 43% in academia. Reporting includes (63%) or subtracts (37%) intervening benign tissue. Both Gleason score and Grade Groups (GG)s were reported by 96% of responders, whereas 94% report percent pattern 4 (%4). Aggregate grading and volume estimation in undesignated cores with different grades in the same jar are reported by 73% and 54% for systematic biopsies, and 83% and 62% for targeted biopsies, respectively. Cribriform morphology was reported by 81%. For presumed intraductal carcinoma (IDC), 89% use basal cell markers when isolated (iIDC), 82% with GG1 cancer, and 37% with ≥GG2. iIDC or IDC associated with GG1 or with ≥GG2 was not graded by 90%, 78%, and 70%, respectively. In radical prostatectomies, 90% report %4, but only 53% report it if the overall grade is ≥7. A tumour with Gleason 3 + 3 = 6 and <5% pattern 4 was graded as GG2 by 64%. A <5% cutoff for defining tertiary pattern was used by 74%, and 80% report >5% pattern 4 or 5 as a secondary pattern. Grading was assigned based on the dominant nodule by 59%. Finally, reporting practices were significantly associated with demographic characteristics. CONCLUSIONS: Although most issues are agreed upon, significant discordance is identified among societies and pathologists in different practice settings. We hope this survey will serve as the basis for future studies and new collaborative approaches to more standardized reporting practices.

来源:Histopathology,查看原文。版权归原作者所有。

引用

  1. Nourbakshs M, Du L, Acosta AM, et al. Current practices in prostate pathology reporting: results from a survey of genitourinary and general pathologists. Histopathology. 2025. PMID: 40364451. doi:10.1111/his.15469

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。